Abstract
Cardiac FDG-PET is emerging as a frequently used imaging modality in the diagnosis of cardiac sarcoidosis; however, there is a scarcity of published data and no uniform consensus on using serial FDG-PET in guiding immunosuppressive therapy in this patient cohort. We studied consecutive patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.